Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population

Sara Tomei, Sharon Adams, Lorenzo Uccellini, Davide Bedognetti, Valeria De Giorgi, Narnygerel Erdenebileg, Maria Libera Ascierto, Jennifer Reinboth, Qiuzhen Liu, Generoso Bevilacqua, Ena Wang, Chiara Mazzanti, Francesco M. Marincola

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

HRAS belongs to the RAS genes superfamily. RAS genes are important players in several human tumors and the single-nucleotide polymorphism rs12628 has been shown to contribute to the risk of bladder, colon, gastrointestinal, oral, and thyroid carcinoma. We hypothesized that this SNP may affect the risk of cutaneous melanoma as well. HRAS gene contains a polymorphic region (rs112587690), a repeated hexanucleotide -GGGCCT- located in intron 1. Three alleles of this region, P1, P2, and P3, have been identified that contain two, three, and four repeats of the hexanucleotide, respectively. We investigated the clinical impact of these polymorphisms in a case-control study. A total of 141 melanoma patients and 118 healthy donors from the North America Caucasian population were screened for rs12628 and rs112587690 polymorphisms. Genotypes were assessed by capillary sequencing or fragment analysis, respectively, and rs12628 CC and rs112587690 P1P1 genotypes significantly associated with increased melanoma risk (OR = 3.83, p = 0.003; OR = 11.3, p = 0.033, respectively), while rs112587690 P1P3 frequency resulted significantly higher in the control group (OR = 0.5, p = 0.017). These results suggest that rs12628 C homozygosis may be considered a potential risk factor for melanoma development in the North American population possibly through the linkage to rs112587690.

Original languageEnglish
Pages (from-to)3456-3461
Number of pages6
JournalMedical Oncology
Volume29
Issue number5
DOIs
Publication statusPublished - Dec 2012
Externally publishedYes

Fingerprint

Melanoma
Population
Single Nucleotide Polymorphism
Genotype
Genes
North America
Thyroid Neoplasms
Introns
Case-Control Studies
Colon
Urinary Bladder
Alleles
Tissue Donors
Control Groups
Skin
Neoplasms

Keywords

  • HRAS
  • Melanoma
  • Polymorphism
  • rs112587690
  • rs12628

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population. / Tomei, Sara; Adams, Sharon; Uccellini, Lorenzo; Bedognetti, Davide; De Giorgi, Valeria; Erdenebileg, Narnygerel; Ascierto, Maria Libera; Reinboth, Jennifer; Liu, Qiuzhen; Bevilacqua, Generoso; Wang, Ena; Mazzanti, Chiara; Marincola, Francesco M.

In: Medical Oncology, Vol. 29, No. 5, 12.2012, p. 3456-3461.

Research output: Contribution to journalArticle

Tomei, S, Adams, S, Uccellini, L, Bedognetti, D, De Giorgi, V, Erdenebileg, N, Ascierto, ML, Reinboth, J, Liu, Q, Bevilacqua, G, Wang, E, Mazzanti, C & Marincola, FM 2012, 'Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population', Medical Oncology, vol. 29, no. 5, pp. 3456-3461. https://doi.org/10.1007/s12032-012-0255-3
Tomei, Sara ; Adams, Sharon ; Uccellini, Lorenzo ; Bedognetti, Davide ; De Giorgi, Valeria ; Erdenebileg, Narnygerel ; Ascierto, Maria Libera ; Reinboth, Jennifer ; Liu, Qiuzhen ; Bevilacqua, Generoso ; Wang, Ena ; Mazzanti, Chiara ; Marincola, Francesco M. / Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population. In: Medical Oncology. 2012 ; Vol. 29, No. 5. pp. 3456-3461.
@article{76d5a5ca3b15480eb3f60eb38834e7a0,
title = "Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population",
abstract = "HRAS belongs to the RAS genes superfamily. RAS genes are important players in several human tumors and the single-nucleotide polymorphism rs12628 has been shown to contribute to the risk of bladder, colon, gastrointestinal, oral, and thyroid carcinoma. We hypothesized that this SNP may affect the risk of cutaneous melanoma as well. HRAS gene contains a polymorphic region (rs112587690), a repeated hexanucleotide -GGGCCT- located in intron 1. Three alleles of this region, P1, P2, and P3, have been identified that contain two, three, and four repeats of the hexanucleotide, respectively. We investigated the clinical impact of these polymorphisms in a case-control study. A total of 141 melanoma patients and 118 healthy donors from the North America Caucasian population were screened for rs12628 and rs112587690 polymorphisms. Genotypes were assessed by capillary sequencing or fragment analysis, respectively, and rs12628 CC and rs112587690 P1P1 genotypes significantly associated with increased melanoma risk (OR = 3.83, p = 0.003; OR = 11.3, p = 0.033, respectively), while rs112587690 P1P3 frequency resulted significantly higher in the control group (OR = 0.5, p = 0.017). These results suggest that rs12628 C homozygosis may be considered a potential risk factor for melanoma development in the North American population possibly through the linkage to rs112587690.",
keywords = "HRAS, Melanoma, Polymorphism, rs112587690, rs12628",
author = "Sara Tomei and Sharon Adams and Lorenzo Uccellini and Davide Bedognetti and {De Giorgi}, Valeria and Narnygerel Erdenebileg and Ascierto, {Maria Libera} and Jennifer Reinboth and Qiuzhen Liu and Generoso Bevilacqua and Ena Wang and Chiara Mazzanti and Marincola, {Francesco M.}",
year = "2012",
month = "12",
doi = "10.1007/s12032-012-0255-3",
language = "English",
volume = "29",
pages = "3456--3461",
journal = "Medical Oncology",
issn = "1357-0560",
publisher = "Humana Press",
number = "5",

}

TY - JOUR

T1 - Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population

AU - Tomei, Sara

AU - Adams, Sharon

AU - Uccellini, Lorenzo

AU - Bedognetti, Davide

AU - De Giorgi, Valeria

AU - Erdenebileg, Narnygerel

AU - Ascierto, Maria Libera

AU - Reinboth, Jennifer

AU - Liu, Qiuzhen

AU - Bevilacqua, Generoso

AU - Wang, Ena

AU - Mazzanti, Chiara

AU - Marincola, Francesco M.

PY - 2012/12

Y1 - 2012/12

N2 - HRAS belongs to the RAS genes superfamily. RAS genes are important players in several human tumors and the single-nucleotide polymorphism rs12628 has been shown to contribute to the risk of bladder, colon, gastrointestinal, oral, and thyroid carcinoma. We hypothesized that this SNP may affect the risk of cutaneous melanoma as well. HRAS gene contains a polymorphic region (rs112587690), a repeated hexanucleotide -GGGCCT- located in intron 1. Three alleles of this region, P1, P2, and P3, have been identified that contain two, three, and four repeats of the hexanucleotide, respectively. We investigated the clinical impact of these polymorphisms in a case-control study. A total of 141 melanoma patients and 118 healthy donors from the North America Caucasian population were screened for rs12628 and rs112587690 polymorphisms. Genotypes were assessed by capillary sequencing or fragment analysis, respectively, and rs12628 CC and rs112587690 P1P1 genotypes significantly associated with increased melanoma risk (OR = 3.83, p = 0.003; OR = 11.3, p = 0.033, respectively), while rs112587690 P1P3 frequency resulted significantly higher in the control group (OR = 0.5, p = 0.017). These results suggest that rs12628 C homozygosis may be considered a potential risk factor for melanoma development in the North American population possibly through the linkage to rs112587690.

AB - HRAS belongs to the RAS genes superfamily. RAS genes are important players in several human tumors and the single-nucleotide polymorphism rs12628 has been shown to contribute to the risk of bladder, colon, gastrointestinal, oral, and thyroid carcinoma. We hypothesized that this SNP may affect the risk of cutaneous melanoma as well. HRAS gene contains a polymorphic region (rs112587690), a repeated hexanucleotide -GGGCCT- located in intron 1. Three alleles of this region, P1, P2, and P3, have been identified that contain two, three, and four repeats of the hexanucleotide, respectively. We investigated the clinical impact of these polymorphisms in a case-control study. A total of 141 melanoma patients and 118 healthy donors from the North America Caucasian population were screened for rs12628 and rs112587690 polymorphisms. Genotypes were assessed by capillary sequencing or fragment analysis, respectively, and rs12628 CC and rs112587690 P1P1 genotypes significantly associated with increased melanoma risk (OR = 3.83, p = 0.003; OR = 11.3, p = 0.033, respectively), while rs112587690 P1P3 frequency resulted significantly higher in the control group (OR = 0.5, p = 0.017). These results suggest that rs12628 C homozygosis may be considered a potential risk factor for melanoma development in the North American population possibly through the linkage to rs112587690.

KW - HRAS

KW - Melanoma

KW - Polymorphism

KW - rs112587690

KW - rs12628

UR - http://www.scopus.com/inward/record.url?scp=84880302935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880302935&partnerID=8YFLogxK

U2 - 10.1007/s12032-012-0255-3

DO - 10.1007/s12032-012-0255-3

M3 - Article

VL - 29

SP - 3456

EP - 3461

JO - Medical Oncology

JF - Medical Oncology

SN - 1357-0560

IS - 5

ER -